Serina Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
SER on NYSE
Industry
Pharmaceutical Preparations
Location
601 Genome Way, Suite 2001, Huntsville, AL

Insiders trading volume in the past year

Serina Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Juvenescence US Corp. Director, 10%+ Owner $9.7M Mar 14, 2023
Gregory Bailey Director $382K +$487K Sep 20, 2024
Steven Mintz Director $247K +$289K Sep 12, 2024
Steven Ledger Chief Executive Officer, Director $134K Sep 9, 2024
Tacey Viegas COO and Secretary $34.6K Mar 26, 2024
Michael D. West Chief Executive Officer $24.8K Mar 11, 2023
Hal Sternberg Vice President-Research Jun 4, 2021
Michael H. May Director Jun 21, 2021
Joanne M. Hackett Director Feb 2, 2022
Juvenescence Ltd Director, 10%+ Owner Apr 25, 2023
Jean-Christophe Renondin Director Aug 9, 2023
Milton Harris Director Apr 1, 2024
Richard Peter Marshall Director Apr 1, 2024
Randall Moreadith Chief Scientific Officer Mar 26, 2024
Judith Segall Director of Admin & Secretary Jun 4, 2021
Annalisa Jenkins Director Jun 21, 2021
Andrea Eun Jae Park Chief Financial Officer Jun 4, 2021
Nafees Malik Chief Operating Officer Jun 4, 2021
Remy Gross Director Apr 1, 2024
Gregory S. Curhan Chief Financial Officer Aug 15, 2024
Srini Tenjarla SVP, CMC & Formulation Jul 15, 2024
Simba Gill Director Apr 15, 2024

Recent Insider Transactions by Companies or Individuals for Serina Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.